Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
QCOR [NASD]
Questcor Pharmaceuticals, Inc.
Index- P/E19.83 EPS (ttm)4.79 Insider Own1.00% Shs Outstand60.98M Perf Week-0.82%
Market Cap5.79B Forward P/E12.28 EPS next Y7.74 Insider Trans-53.94% Shs Float59.97M Perf Month2.29%
Income327.90M PEG0.67 EPS next Q1.74 Inst Own- Short Float30.00% Perf Quarter21.98%
Sales890.90M P/S6.50 EPS this Y51.60% Inst Trans0.64% Short Ratio10.57 Perf Half Y53.28%
Book/sh7.93 P/B11.98 EPS next Y12.30% ROA52.50% Target Price86.14 Perf Year103.38%
Cash/sh5.51 P/C17.24 EPS next 5Y29.47% ROE96.90% 52W Range45.14 - 97.80 Perf YTD76.68%
Dividend1.20 P/FCF17.51 EPS past 5Y57.60% ROI70.60% 52W High-2.86% Beta0.97
Dividend %1.26% Quick Ratio2.50 Sales past 5Y53.00% Gross Margin91.10% 52W Low110.47% ATR2.19
Employees490 Current Ratio2.60 Sales Q/Q68.10% Oper. Margin55.60% RSI (14)56.70 Volatility1.41% 2.43%
OptionableYes Debt/Eq0.03 EPS Q/Q84.60% Profit Margin41.20% Rel Volume0.64 Prev Close94.75
ShortableYes LT Debt/Eq0.03 EarningsJul 28 Payout17.70% Avg Volume1.70M Price95.00
Recom2.70 SMA201.99% SMA504.35% SMA20034.09% Volume1,094,200 Change0.26%
20-May-14Downgrade Mizuho Buy → Neutral $92
21-Apr-14Reiterated Oppenheimer Outperform $99 → $86
26-Feb-14Reiterated Oppenheimer Outperform $90 → $99
26-Feb-14Reiterated Ladenburg Thalmann Buy $84 → $85
26-Feb-14Reiterated CRT Capital Fair Value $61 → $72
30-Oct-13Reiterated Mizuho Buy $84 → $93
30-Oct-13Downgrade CRT Capital Buy → Fair Value
19-Aug-13Reiterated Oppenheimer Outperform $57 → $73
12-Aug-13Reiterated Mizuho Buy $65 → $84
31-Jul-13Reiterated Oppenheimer Outperform $57 → $73
31-Jul-13Reiterated Mizuho Buy $62 → $65
31-Jul-13Reiterated Ladenburg Thalmann Buy $54 → $66
30-Jul-13Reiterated Mizuho Buy $50 → $62
21-Jun-13Resumed Oppenheimer Outperform $57
11-Jun-13Upgrade CRT Capital Hold → Buy $52
15-May-13Reiterated Mizuho Buy $41 → $50
01-May-13Reiterated Ladenburg Thalmann Buy $38 → $35
27-Feb-13Reiterated Ladenburg Thalmann Buy $33 → $38
21-Feb-13Upgrade Mizuho Neutral → Buy $28 → $41
30-Nov-12Initiated Mizuho Neutral $28
17-Jul-14 01:30PM  Acthar's Future Could Be An Adverse Event For Mallinckrodt at Seeking Alpha
15-Jul-14 04:54PM  Are Questcor Shareholders Getting A Good Deal? at Seeking Alpha
02:43PM  Dumb Investment Of The Week: Mallinckrodt Plc at Seeking Alpha
09:29AM  Update-Moody's assigns Ba2 to Mallinckrodt's new sr. secured term loan Reuters
14-Jul-14 03:09PM  Questcor rises after S-4 effective, interest from other suitors disclosed at theflyonthewall.com
07:00AM  Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction PR Newswire
11-Jul-14 04:34PM  Questcor Discloses Side Effect Data for its Achtar Drug for the First Time at The Wall Street Journal
09:33AM  Questcor Comes Clean On Acthar; NY Times Seems To Confirm FDA Interest at Seeking Alpha
06:39AM  Questcor reports Acthar adverse effects data, NY Times says theflyonthewall.com
10-Jul-14 06:42PM  Questcor Reveals Adverse Events Data for Acthar for First Time at New York Times
06:42PM  Questcor Reveals Adverse Events Data for Acthar for First Time at New York Times
12:34PM  Questcor's Acthar: Refuting A Long's Optimism With Irrefutable Facts at Seeking Alpha
06:32AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:28AM  Questcor's Acthar Gel: Clinical Usage Suggests Efficacy at Seeking Alpha
07-Jul-14 09:45AM  Questcor Pharmaceuticals (QCOR) Hits New Lifetime High Today at TheStreet
02-Jul-14 07:09PM  What Stocks Top Funds Are Buying Now at Investor's Business Daily
30-Jun-14 06:07PM  Questcor And Mallinckrodt: The Good, The Bad, And The Ugly at Seeking Alpha
11:53AM  Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar at Seeking Alpha
26-Jun-14 05:47PM  Why Small-Cap Stocks ARRIS and Questcor Have Huge Growth Potential at Motley Fool
05:47PM  Why Small-Cap Stocks ARRIS and Questcor Have Huge Growth Potential
25-Jun-14 01:49PM  The FDA Owes Us An Answer On Questcor's Acthar at Seeking Alpha
01:49PM  The FDA Owes Us An Answer On Questcor's Acthar
23-Jun-14 09:00AM  Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot PR Newswire
09:00AM  Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot
08:00AM  Aging stinks, so at least make some money from it at CNBC
08:00AM  Aging stinks, so at least make some money from it
21-Jun-14 02:44AM  [$$] Follow Up at Barrons.com
02:44AM  [$$] Follow Up
17-Jun-14 06:41PM  Top Value Funds Vs. Top Growth Funds at Investor's Business Daily
06:41PM  Top Value Funds Vs. Top Growth Funds
09:27AM  Questcor: Another Serious Reason To Be A Skeptic at Seeking Alpha
09:27AM  Questcor: Another Serious Reason To Be A Skeptic
13-Jun-14 06:39AM  Mallinckrodt merger proxy doesn't disclose Questcor risks, NY Times reports at theflyonthewall.com
06:39AM  Mallinckrodt merger proxy doesn't disclose Questcor risks, NY Times reports
12-Jun-14 03:41PM  Drug Merger Discussion Leaves Out A Key Risk at New York Times
03:41PM  A Drugs Risks Are Left Out in Discussion of Questcor Deal at New York Times
06-Jun-14 03:53PM  Questcor's 'Buyout' Could Fall Through at Seeking Alpha
03:53PM  Questcor's 'Buyout' Could Fall Through
05-Jun-14 03:37PM  Mallinckrodt, Questcor both down after Cigna comments on Acthar Gel at theflyonthewall.com
03:37PM  Mallinckrodt, Questcor both down after Cigna comments on Acthar Gel
08:02AM  Lannett Tops Trio Of Medical Small Cap Leaders at Investor's Business Daily
08:02AM  Lannett Tops Trio Of Medical Small Cap Leaders
03-Jun-14 10:28AM  Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts PR Newswire
10:28AM  Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts
28-May-14 03:28PM  Questcor Receives "Recognition of Appreciation" Award from MS Views & News PR Newswire
03:28PM  Questcor Receives "Recognition of Appreciation" Award from MS Views & News
26-May-14 10:06AM  Free Speech and the FDA: Are Radical Changes Incoming? at Motley Fool
23-May-14 01:01PM  [video] Debate in small caps at CNBC
01:01PM  [video] Debate in small caps
22-May-14 07:45PM  3 Stocks Near 52-Week Highs Worth Selling at Motley Fool
05:57AM  Stocks with implied volatility movement; GME QCOR at theflyonthewall.com
21-May-14 05:56AM  Stocks with implied volatility movement; BBY QCOR at theflyonthewall.com
20-May-14 06:29AM  Questcor downgraded to Neutral from Buy at Mizuho at theflyonthewall.com
06:00AM  Questcor Pharma downgraded by Mizuho Briefing.com
05:55AM  Stocks with implied volatility movement; QCOR XLU at theflyonthewall.com
16-May-14 01:03PM  Today's Stocks Driving Success For The Health Care Sector at TheStreet
06:02AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
15-May-14 08:01AM  Questcor (QCOR) is Overbought: Is A Drop Coming? Zacks
14-May-14 02:06PM  Questcor volatility at low end of historic range at theflyonthewall.com
09:03AM  Questcor signs development collaboratiion agreement with European company at theflyonthewall.com
09:00AM  Questcor Enters Into Development Collaboration Agreement Covering Novel Receptor-Selective Melanocortin Peptides PR Newswire
13-May-14 02:41PM  FDA approval of generic Exalgo negative for Mallinckrodt, says BMO Capital at theflyonthewall.com
12-May-14 11:40AM  FMR lowers passive stake in Questcor to 1.99% from 8.8% at theflyonthewall.com
07:17AM  Questcor downgraded to Neutral from Overweight at Piper Jaffray at theflyonthewall.com
07:05AM  Mallinckrodt, Questcor announce early termination of HSR Act waiting period at theflyonthewall.com
07:02AM  Mallinckrodt price target raised to $85 from $77 at Jefferies at theflyonthewall.com
07:00AM  Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce Early Termination of HSR Act Waiting Period Business Wire
11-May-14 05:45AM  Industry Ranks May 2014 at Seeking Alpha
09-May-14 05:53AM  Stocks with implied volatility movement; QCOR XLE at theflyonthewall.com
08-May-14 11:19AM  Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed at Investor's Business Daily
06-May-14 01:04PM  QUESTCOR PHARMACEUTICALS INC Financials EDGAR Online Financials
12:11PM  Akorn Q1 EPS Beats, Raises Full-Year Profit Outlook at Investor's Business Daily
06:03AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
05-May-14 09:00AM  Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus PR Newswire
02-May-14 04:51PM  When Giant Funds Go Small, Here's Where They Go at Barrons.com
12:20PM  Questcor CEO's Daughter Granted Huge Pay Raise at TheStreet
01-May-14 12:00PM  How Hedge Funds Are Pushing Companies To Leave America at Forbes
30-Apr-14 11:55AM  INVESTOR ALERT Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt Business Wire
29-Apr-14 01:58PM  QUESTCOR PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
10:40AM  Questcor Misses on Earnings & Revs in Q1 Zacks
10:38AM  Hedge fund JANA reports new positions in Walgreen, AerCap at theflyonthewall.com
28-Apr-14 07:30PM  QUESTCOR (QCOR) SHAREHOLDER ALERT - The Law firm of Andrews & Springer LLC Announces An Investigation of Questcor Pharmaceuticals, Inc. PR Newswire
05:30PM  Growth in Acthar Gel Pushes Questcor's Profits Up by 84% in Q1 at Motley Fool
04:36PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Questcor Pharmaceuticals, Inc. of Claims of Breaches of Fiduciary Duty Against Its Board of Directors in Connection With the Sale of the Company to Mallinckrodt -- QCOR Marketwired
04:01PM  Questcor Reports First Quarter Financial Results PR Newswire
03:25PM  Novel Oncology and Hepatitis C Treatments Are Boosting Pharmaceutical Stocks: Citigroup Investment Global Head of Healthcare Research & Analysis Andrew Baum, M.D. Interviews with the Wall Street Transcript Wall Street Transcript
07:07AM  Q1 2014 Questcor Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
25-Apr-14 11:48AM  Joel Ackerman, the CEO of Champions Oncology, Inc. (CSBR), Interviews with The Wall Street Transcript Wall Street Transcript
24-Apr-14 10:58AM  Paulson action positive for Mallinckrodt, Questcor, says BMO Capital at theflyonthewall.com
07:00AM  Questcor to Report First Quarter Financial Results on April 28, 2014 PR Newswire
23-Apr-14 12:47PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Questcor Pharmaceuticals, Inc. of Claims of Breaches of Fiduciary Duty Against Its Board of Directors in Connection With the Sale of the Company to Mallinckrodt -- QCOR GlobeNewswire
01:54AM  Valeant Pharmaceuticals International (VRX) Soars: Stock Up 7.5% Zacks
22-Apr-14 04:40PM  Eli Lilly to Acquire Novartis' Animal Health Biz Zacks
21-Apr-14 09:00AM  Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy PR Newswire
17-Apr-14 09:00AM  Questcor Partners with National Kidney Foundation as National Sponsor of Kidney Walk PR Newswire
15-Apr-14 06:40AM  Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% Zacks
14-Apr-14 07:45PM  QUESTCOR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. Over the Proposed Sale of the Company to Mallinckrodt plc PR Newswire
10:30AM  3 Humongous Health-Care Stocks This Week at Motley Fool
11-Apr-14 02:21PM  INVESTOR ALERT Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt Business Wire
12:30PM  Lifshitz & Miller Law Firm Announces Investigation of Imperva, Inc., OBA Financial Services, Inc., Och-Ziff Capital Management Group LLC, Questcor Pharmaceuticals, Inc., Vocus, Inc. and Zygo Corporation PR Newswire
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of autoimmune and inflammatory disorders. The company primarily offers H.P. Acthar Gel, an injectable drug to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus; as exacerbation or maintenance therapy in various cases of systemic lupus erythematosus and systemic dermatomyositis; and as adjunctive therapy for short-term administration in psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis. Its H.P. Acthar Gel is also used for the treatment of acute exacerbations of multiple sclerosis in adults; and as monotherapy for the treatment of infantile spasms in infants and children under two years of age. The company sells its product primarily to specialty pharmacies. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAILEY DON MSee RemarksJul 14Option Exercise5.1240,000204,800139,000Jul 16 05:07 PM
BAILEY DON MSee RemarksJul 14Sale95.5440,0003,821,70099,000Jul 16 05:07 PM
Young DavidChief Scientific OfficerJun 24Option Exercise4.546,00027,240117,741Jun 26 07:50 PM
Young DavidChief Scientific OfficerJun 24Sale91.966,000551,764117,741Jun 26 07:50 PM
BAILEY DON MPresident and CEOJun 13Option Exercise5.1240,000204,800139,000Jun 17 07:08 PM
BAILEY DON MPresident and CEOJun 13Sale89.8340,0003,593,08599,000Jun 17 07:08 PM
Mulroy Michael H.See RemarksJun 10Option Exercise14.2410,000142,40087,063Jun 12 06:43 PM
Mulroy Michael H.See RemarksJun 10Sale88.5710,000885,74577,063Jun 12 06:43 PM
FARRELL STEPHEN CDirectorJun 02Sale89.943,750337,27411,683Jun 04 06:38 PM
Medeiros David JeffreyEVP and CTOMay 19Option Exercise25.992,29259,563122,331May 21 07:35 PM
Medeiros David JeffreyEVP and CTOMay 19Sale89.662,292205,501120,039May 21 07:35 PM
BRADSHER NEAL CDirectorMay 14Option Exercise0.847,5006,30011,683May 16 05:39 PM
BAILEY DON MPresident and CEOMay 13Option Exercise5.1240,000204,800139,000May 15 06:24 PM
BAILEY DON MPresident and CEOMay 13Sale87.0540,0003,481,81099,000May 15 06:24 PM
Mulroy Michael H.See RemarksMay 12Option Exercise14.2410,000142,40087,063May 14 06:05 PM
Mulroy Michael H.See RemarksMay 12Sale87.9910,000879,90877,063May 14 06:05 PM
Medeiros David JeffreyEVP and CTOApr 21Option Exercise25.992,29259,563122,331Apr 23 07:41 PM
Medeiros David JeffreyEVP and CTOApr 21Sale77.152,292176,828120,039Apr 23 07:41 PM
BAILEY DON MPresident and CEOApr 14Option Exercise5.1240,000204,800139,000Apr 15 08:45 PM
BAILEY DON MPresident and CEOApr 14Sale79.6540,0003,186,18999,000Apr 15 08:45 PM
Mulroy Michael H.See RemarksApr 10Option Exercise14.2410,000142,40087,063Apr 14 07:09 PM
Mulroy Michael H.See RemarksApr 10Sale85.0410,000850,40077,063Apr 14 07:09 PM
SILVERMAN LOUDirectorApr 07Option Exercise4.0810,00040,80024,183Apr 09 08:08 PM
SILVERMAN LOUDirectorApr 07Sale84.5710,000845,70014,183Apr 09 08:08 PM
BROADWOOD PARTNERS LPDirectorApr 07Sale83.96205,00017,212,0872,046,660Apr 09 05:45 PM
FARRELL STEPHEN CDirectorApr 07Sale84.577,500634,27520,433Apr 07 07:24 PM
FARRELL STEPHEN CDirectorApr 03Sale72.002,500180,00020,433Apr 07 07:24 PM
Young DavidChief Scientific OfficerMar 14Option Exercise4.546,00027,240117,741Mar 18 04:05 PM
Young DavidChief Scientific OfficerMar 14Sale62.286,000373,669111,741Mar 18 04:05 PM
BAILEY DON MPresident and CEOMar 13Option Exercise5.1240,000204,800139,000Mar 17 04:05 PM
BAILEY DON MPresident and CEOMar 13Sale62.7140,0002,508,29299,000Mar 17 04:05 PM
Mulroy Michael H.See RemarksMar 10Option Exercise14.2410,000142,40087,063Mar 12 06:16 PM
Mulroy Michael H.See RemarksMar 10Sale64.8010,000647,99177,063Mar 12 06:16 PM
FARRELL STEPHEN CDirectorMar 07Sale65.215,000326,06415,433Mar 11 08:01 PM
Medeiros David JeffreyEVP and CTOMar 03Option Exercise35.7883429,841120,873Mar 05 07:47 PM
Young DavidChief Scientific OfficerMar 03Option Exercise5.776,00034,620111,741Mar 05 07:43 PM
Medeiros David JeffreyEVP and CTOMar 03Sale62.0083451,708120,039Mar 05 07:47 PM
BROADWOOD PARTNERS LPDirectorFeb 25Sale80.0812,6001,008,9462,251,660Feb 26 06:02 PM
Young DavidChief Scientific OfficerFeb 24Option Exercise4.546,00027,240111,351Feb 26 08:03 PM
BROADWOOD PARTNERS LPDirectorFeb 24Sale79.5071,0005,644,8412,264,260Feb 26 06:02 PM
Young DavidChief Scientific OfficerFeb 24Sale78.886,000473,290105,351Feb 26 08:03 PM
BROADWOOD PARTNERS LPDirectorFeb 20Sale77.7391,4007,104,8512,335,260Feb 20 06:06 PM
Medeiros David JeffreyEVP and CTOFeb 19Option Exercise25.992,29259,563120,343Feb 21 06:39 PM
Medeiros David JeffreyEVP and CTOFeb 19Sale75.022,292171,935118,051Feb 21 06:39 PM
BROADWOOD PARTNERS LPDirectorFeb 19Sale76.026,500494,1612,426,660Feb 20 06:06 PM
BROADWOOD PARTNERS LPDirectorFeb 18Sale73.68208,50015,361,9262,433,160Feb 20 06:06 PM
BAILEY DON MPresident and CEOFeb 13Option Exercise5.1140,000204,400139,000Feb 18 07:44 PM
BAILEY DON MPresident and CEOFeb 13Sale69.5640,0002,782,30599,000Feb 18 07:44 PM
BROADWOOD PARTNERS LPDirectorFeb 12Sale69.8337,0002,583,7472,641,660Feb 13 05:32 PM
BROADWOOD PARTNERS LPDirectorFeb 11Sale68.5448,0003,289,8862,678,660Feb 13 05:32 PM
BROADWOOD PARTNERS LPDirectorJan 30Sale67.0125,0001,675,3502,726,660Jan 31 05:52 PM
Young DavidChief Scientific OfficerJan 29Option Exercise7.5420,000150,800111,145Jan 31 08:19 PM
BROADWOOD PARTNERS LPDirectorJan 29Sale66.1025,0001,652,3752,751,660Jan 31 05:52 PM
Medeiros David JeffreyEVP and CTOJan 27Option Exercise35.7883329,805118,884Jan 29 08:07 PM
Medeiros David JeffreyEVP and CTOJan 27Sale63.7383353,087118,051Jan 29 08:07 PM
Young DavidChief Scientific OfficerJan 24Option Exercise4.546,00027,24097,145Jan 28 07:46 PM
Young DavidChief Scientific OfficerJan 24Sale64.386,000386,29491,145Jan 28 07:46 PM
Medeiros David JeffreyEVP and CTOJan 23Option Exercise18.47129,4782,391,161166,280Jan 23 08:26 PM
BROADWOOD PARTNERS LPDirectorJan 23Sale65.0020,0001,300,0002,776,660Jan 27 06:35 PM
Medeiros David JeffreyEVP and CTOJan 23Sale65.00129,4788,416,070118,051Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 21Option Exercise16.894,06368,631119,822Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 21Sale62.004,063251,906118,051Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 16Option Exercise5.1150,000255,700153,051Jan 21 08:21 PM
Medeiros David JeffreyEVP and CTOJan 16Sale62.0050,0003,100,000118,051Jan 21 08:21 PM
BAILEY DON MPresident and CEOJan 13Option Exercise5.1040,000204,000139,000Jan 15 08:30 PM
BAILEY DON MPresident and CEOJan 13Sale53.6440,0002,145,59399,000Jan 15 08:30 PM
BAILEY DON MPresident and CEODec 13Option Exercise5.1040,000204,000139,000Dec 17 05:54 PM
BAILEY DON MPresident and CEODec 13Sale53.3040,0002,132,16899,000Dec 17 05:54 PM
Young DavidChief Scientific OfficerNov 19Option Exercise5.7715,00086,55089,603Nov 21 05:20 PM
BRADSHER NEAL CDirectorNov 14Option Exercise0.8640,00034,25044,183Nov 15 07:28 PM
BRADSHER NEAL CDirectorNov 14Sale62.4140,0002,496,2374,183Nov 15 07:28 PM
BAILEY DON MPresident and CEONov 13Option Exercise5.1040,000204,000139,000Nov 15 07:06 PM
Young DavidChief Scientific OfficerNov 13Option Exercise4.54100,000454,000174,603Nov 15 07:10 PM
Young DavidChief Scientific OfficerNov 13Sale62.40100,0006,240,03074,603Nov 15 07:10 PM
BAILEY DON MPresident and CEONov 13Sale62.4440,0002,497,52399,000Nov 15 07:06 PM
BROADWOOD PARTNERS LPDirectorNov 13Sale62.56174,03410,886,8012,796,660Nov 13 07:15 PM
BROADWOOD PARTNERS LPDirectorNov 12Sale62.28195,84412,197,2432,970,694Nov 13 07:15 PM
BROADWOOD PARTNERS LPDirectorNov 11Sale62.25130,1228,099,7953,166,538Nov 13 07:15 PM
BAILEY DON MPresident and CEOOct 14Option Exercise5.1040,000204,000139,000Oct 16 06:51 PM
THOMPSON VIRGIL DDirectorOct 14Option Exercise4.502,50011,25032,367Oct 16 06:57 PM
THOMPSON VIRGIL DDirectorOct 14Sale60.502,500151,25429,867Oct 16 06:57 PM
BAILEY DON MPresident and CEOOct 14Sale62.1640,0002,486,53299,000Oct 16 06:51 PM
THOMPSON VIRGIL DDirectorSep 16Option Exercise4.505,00022,50034,867Sep 18 07:02 PM
THOMPSON VIRGIL DDirectorSep 16Sale63.755,000318,73629,867Sep 18 07:02 PM
BAILEY DON MPresident and CEOSep 13Option Exercise5.1040,000204,000139,000Sep 17 05:33 PM
BAILEY DON MPresident and CEOSep 13Sale63.6940,0002,547,76699,000Sep 17 05:33 PM
Medeiros David JeffreyEVP and CTOAug 26Option Exercise5.1055,000280,500172,121Aug 27 08:02 PM
Medeiros David JeffreyEVP and CTOAug 26Sale73.9855,0004,068,984117,121Aug 27 08:02 PM
THOMPSON VIRGIL DDirectorAug 14Option Exercise5.775,00028,85034,867Aug 16 05:56 PM
THOMPSON VIRGIL DDirectorAug 14Sale69.125,000345,57729,867Aug 16 05:56 PM
Medeiros David JeffreyEVP and CTOAug 13Option Exercise2.45110,597270,815195,649Aug 15 06:16 PM
Medeiros David JeffreyEVP and CTOAug 13Sale67.85110,5977,503,745117,121Aug 15 06:16 PM
Medeiros David JeffreyEVP and CTOAug 06Option Exercise5.0248,831245,202165,052Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 06Sale66.7348,8313,258,485117,121Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 05Option Exercise1.3710,00013,700127,121Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 05Sale66.5110,000665,134117,121Aug 07 09:45 PM